PDS Biotechnology Corporation
DE ˙ DB ˙ US70465T1079
0,99 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:EU6 / PDS Biotechnology Corporation
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership220,800 shares
Latest Disclosed Value $ 133,584
Renaissance Technologies Llc reports 24.96% increase in ownership of EU6 / PDS Biotechnology Corporation

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 220,800 shares of PDS Biotechnology Corporation (DE:EU6) valued at $102,584 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 176,700 shares of PDS Biotechnology Corporation. This represents a change in shares of 24.96% during the quarter. The current value of the position is $219,475 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 220,800 44,100 24.96 134 -2.21 0.0002
2026-02-12 2025-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 176,700 -99,161 -35.95 136 -51.08 0.0002
2025-11-13 2025-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 275,861 170,174 161.02 279 98.57 0.0004
2025-08-13 2025-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 105,687 105,687 141 0.0002
2025-05-14 2025-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 0 -100,000 -100.00 0 -100.00
2025-02-13 2024-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 100,000 76,800 331.03 163 85.23 0.0002
2024-11-13 2024-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 23,200 23,200 89 0.0001
2024-08-09 2024-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 0 -354,800 -100.00 0 -100.00
2024-05-13 2024-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 354,800 234,100 193.95 1 0.0022
2024-02-13 2023-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 120,700 120,700 1 0.0009
2023-11-14 2023-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 0 -22,862 -100.00 0 0.0000
2023-08-11 2023-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 22,862 -342,875 -93.75 0 -100.00 0.0002
2023-05-12 2023-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 365,737 118,400 47.87 2 -33.33 0.0030
2023-02-13 2022-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 247,337 -74,987 -23.26 3 -99.69 0.0045
2022-11-14 2022-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 322,324 -68,713 -17.57 957 -32.94 0.0014
2022-08-12 2022-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 391,037 -274,000 -41.20 1,427 -65.34 0.0017
2022-05-13 2022-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 665,037 220,300 49.53 4,117 14.30 0.0048
2022-02-11 2021-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 444,737 78,900 21.57 3,602 -33.92 0.0045
2021-11-12 2021-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 365,837 -89,620 -19.68 5,451 -4.64 0.0070
2021-08-13 2021-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 455,457 -212,290 -31.79 5,716 88.15 0.0071
2021-05-13 2021-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 667,747 -160,974 -19.42 3,038 71.35 0.0038
2021-02-10 2020-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 828,721 44,864 5.72 1,773 -2.90 0.0019
2020-11-13 2020-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 783,857 161,185 25.89 1,826 45.85 0.0018
2020-08-13 2020-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 622,672 313,051 101.11 1,252 453.98 0.0011
2020-05-14 2020-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 309,621 189,352 157.44 226 -29.15 0.0002
2020-02-13 2019-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 120,269 28,700 31.34 319 3.24 0.0002
2019-11-13 2019-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 91,569 13,100 16.69 309 -34.26 0.0003
2019-08-12 2019-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 78,469 38,105 94.40 470 57.19 0.0004
2019-05-14 2019-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 40,364 40,364 299 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.